Literature DB >> 29968173

Federal Response to the Opioid Crisis.

Kimberly Johnson1,2, Chris Jones3, Wilson Compton4, Grant Baldwin5, Jennifer Fan6, Jonathan Mermin5, Jean Bennett6.   

Abstract

PURPOSE OF REVIEW: In light of the current crisis in opioid involved overdose deaths, the federal Department of Health and Human Services operating divisions are working together to implement a data-driven, research-based strategy to reduce opioid misuse and its consequences. RECENT
FINDINGS: The strategy has five elements: (1) strengthening public health data collection and reporting; (2) advancing the practice of pain management; (3) improving access to addiction prevention, treatment, and recovery support services; (4) increasing availability of overdose-reversing drugs; and (5) supporting cutting-edge research in treatment of pain, opioid use disorder, and associated conditions. The Department of Health and Human Services has developed a concerted, coordinated evidence-based effort across department divisions to reduce opioid misuse, prevalence of opioid use disorder, and reduce deaths due to opioid use.

Entities:  

Keywords:  Federal response; HIV; Opioid epidemic

Mesh:

Substances:

Year:  2018        PMID: 29968173     DOI: 10.1007/s11904-018-0398-8

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  41 in total

1.  Effect of the first federally funded US antismoking national media campaign.

Authors:  Tim McAfee; Kevin C Davis; Robert L Alexander; Terry F Pechacek; Rebecca Bunnell
Journal:  Lancet       Date:  2013-09-09       Impact factor: 79.321

Review 2.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

3.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

4.  Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Bruce R Schackman; Tim Matheson; Moupali Das; Matthew R Golden; Shannon Huffaker; Louise F Haynes; Susan Tross; C Kevin Malotte; Antoine Douaihy; P Todd Korthuis; Wayne A Duffus; Sarah Henn; Robert Bolan; Susan S Philip; Jose G Castro; Pedro C Castellon; Gayle McLaughlin; Raul N Mandler; Bernard Branson; Grant N Colfax
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

5.  Why aren't physicians prescribing more buprenorphine?

Authors:  Andrew S Huhn; Kelly E Dunn
Journal:  J Subst Abuse Treat       Date:  2017-04-12

6.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

7.  How to eliminate HCV in people who inject drugs in the USA.

Authors:  Harel Dahari; Basmattee Boodram
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071

Review 8.  Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review.

Authors:  Ellen L Bassuk; Justine Hanson; R Neil Greene; Molly Richard; Alexandre Laudet
Journal:  J Subst Abuse Treat       Date:  2016-01-13

9.  Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Authors:  Natasha K Martin; Matthew Hickman; Sharon J Hutchinson; David J Goldberg; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

10.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

View more
  12 in total

1.  Association Between the Number of Certified Buprenorphine Prescribers and the Quantity of Buprenorphine Prescriptions: Evidence from 2015 to 2017.

Authors:  Lee-Kai Lin; Kosali Simon; Alex Hollingsworth; Brendan Saloner
Journal:  J Gen Intern Med       Date:  2019-11       Impact factor: 5.128

2.  Differences in hope, core self-evaluations, emotional well-being, and health risk behaviors in freshman university students.

Authors:  Stephanie Griggs; Sybil L Crawford
Journal:  Nurs Forum       Date:  2019-07-16

Review 3.  Ethical issues associated with solid organ transplantation and substance use: a scoping review.

Authors:  Lauren Notini; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Monash Bioeth Rev       Date:  2019-12

4.  Unclassified drug overdose deaths in the opioid crisis: emerging patterns of inequity.

Authors:  Andrew J Boslett; Alina Denham; Elaine L Hill; Meredith C B Adams
Journal:  J Am Med Inform Assoc       Date:  2019-08-01       Impact factor: 4.497

5.  Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Jenna Neasbitt; Chad Sobora; Robert Riley; Lesley Weinstein; Aaron Laxton; Justin Kunzelman; Kyle Kampman; Brenda Curtis
Journal:  Addict Behav       Date:  2019-06-21       Impact factor: 3.913

6.  Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States.

Authors:  Lewei Allison Lin; Hannah K Knudsen
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

7.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

Review 8.  Methodological Complexities in Quantifying Rates of Fatal Opioid-Related Overdose.

Authors:  Svetla Slavova; Chris Delcher; Jeannine M Buchanich; Terry L Bunn; Bruce A Goldberger; Julia F Costich
Journal:  Curr Epidemiol Rep       Date:  2019-05-02

Review 9.  Neuroleptanalgesia for acute abdominal pain: a systematic review.

Authors:  Andrew C Miller; Abbas M Khan; Alberto A Castro Bigalli; Kerry A Sewell; Alexandra R King; Shadi Ghadermarzi; Yuxuan Mao; Shahriar Zehtabchi
Journal:  J Pain Res       Date:  2019-02-26       Impact factor: 3.133

10.  Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study.

Authors:  Cynthia B Sinha; Nitya Bakshi; Diana Ross; Lakshmanan Krishnamurti
Journal:  JAMA Netw Open       Date:  2019-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.